Mednet Logo
HomeHematologyQuestion

When do you choose to give CyBorD over RVd in a newly diagnosed myeloma patient?

6
2 Answers
Mednet Member
Mednet Member
Medical Oncology · Winship Cancer Institute of Emory University

I only use VCd when patients are going to be inpatient for a while or the patient is unable to afford an IMiD. For patients with renal insufficiency, where time is of the essence, I recommend Velcade 1.3 mg/m2 SQ days 1,4,8,11 + dex 20 mg days 1,4,8,11 with Revlimid 5-15 mg in newly diagnosed MM.

L...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Memorial Sloan Kettering Cancer Center

agree with Craig's take

Register or Sign In to see full answer